Product Information
MINOCYCLINE 75 MG CAPSULE is a generic product labeled by Actavis Pharma, Inc., priced at $0.4244 per EA under NDC 00591315301. Its NADAC has been published 662 times since Nov 28, 2013.
FDA first approved this application on Dec 30, 1991. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
75 mg/1
Manufacturer
Actavis Pharma, Inc.NDC
00591315301
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
7/22/2026
Active Ingredients
MINOCYCLINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA063065FDA Approved
12/30/1991
TE Code
AB
On Market Since
9/17/2002
Pharmacological Classes
Price Statistics
The NADAC for MINOCYCLINE 75 MG CAPSULE has been published 662 times since Nov 28, 2013, and over the history we have for it it has risen 49.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.4244 per EA |
|---|---|
| All-time high | $0.5390 (May 16, 2018) |
| All-time low | $0.2623 (Aug 20, 2014) |
| 52-week high | $0.4410 |
| 52-week low | $0.4004 |
| Median price | $0.4066 |
| Average price | $0.3997 |
| Largest weekly change | +42.7% (Jan 21, 2015) |
| Weeks tracked | 662 |
| Tracking since | Nov 28, 2013 |
1W
N/A
1M
0.0%
3M
-0.6%
6M
+1.4%
1Y
-1.8%
3Y
-1.3%
5Y
-4.3%
All
+49.3%
Last surveyed Jul 29, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 4% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of MINOCYCLINE 75 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for MINOCYCLINE 75 MG CAPSULE, manufactured by Actavis Pharma, Inc., is $0.4244 per EA (NDC 00591315301), effective Jul 29, 2026.
How has the price of MINOCYCLINE 75 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for MINOCYCLINE 75 MG CAPSULE has risen 49.3%. It has been tracked across 662 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for MINOCYCLINE 75 MG CAPSULE?
Since Nov 28, 2013, the NADAC for MINOCYCLINE 75 MG CAPSULE has ranged from a low of $0.2623 (Aug 20, 2014) to a high of $0.5390 (May 16, 2018), with a median of $0.4066 per EA.
Are there cheaper alternatives to MINOCYCLINE 75 MG CAPSULE?
Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, MINOCYCLINE 75 MG CAPSULE, is $0.4054 per EA — about 4% below MINOCYCLINE 75 MG CAPSULE.
Who manufactures MINOCYCLINE 75 MG CAPSULE?
MINOCYCLINE 75 MG CAPSULE (NDC 00591315301) is labeled by Actavis Pharma, Inc., and CMS classifies it as a generic product.